You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Endothelin Receptor Antagonists

Showing 1 - 25 of 8,448
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ive Alzheimer's Medicines - PDE5 Inhibitors vs Endothelin

Active, not recruiting
  • Pulmonary Arterial Hypertension
  • PDE5 inhibitor
  • Endothelin Receptor Antagonists
  • Boston, Massachusetts
    Brigham and Women's Hospital
Nov 15, 2021

Pharmacogenomics in Pulmonary Arterial Hypertension

Withdrawn
  • Pulmonary Arterial Hypertension
  • +2 more
  • Pittsburgh, Pennsylvania
    Allegheny General Hospital
Nov 29, 2021

Hypertension Trial in Augusta (Candesartan, Placebo)

Active, not recruiting
  • Hypertension
  • Augusta, Georgia
    Georgia Prevention Institute/ Laboratory of Integrative and Exer
Jul 18, 2022

Breast Cancer, Chemo-induced Nausea and Vomiting Trial in Hanzhou (Aprepitant, Palonosetron, Fosaprepitant)

Not yet recruiting
  • Breast Cancer
  • Chemotherapy-induced Nausea and Vomiting
  • Hanzhou, Zhejiang, China
    the Second Affiliated Hospital of Zhejiang Univercity School of
Apr 23, 2023

Primary Aldosteronism Trial in Montréal (Renin measurements)

Not yet recruiting
  • Primary Aldosteronism
  • Renin measurements
  • Montréal, Quebec, Canada
    Hôpital du Sacré-Coeur de Montréal
Oct 30, 2023

Hypertension Trial in Augusta (Bosentan, Placebo)

Active, not recruiting
  • Hypertension
  • Augusta, Georgia
    Georgia Regents University
Jul 18, 2022

Renin Angiotensin Aldosterone System Genetic Polymorphism on

Recruiting
  • Myocardial Infarction
    • Cairo, Egypt
      Ain Shams University
    May 16, 2023

    Pediatric Cancer Trial in Yerevan (Ondansetron, Dexamethasone)

    Not yet recruiting
    • Pediatric Cancer
    • Yerevan, Armenia
      Hematology Center named after prof. R. Yeolyan
    May 23, 2023

    Chronic Kidney Diseases Trial in Worldwide (Zibotentan, Dapagliflozin, Placebo)

    Enrolling by invitation
    • Chronic Kidney Diseases
    • Aurora, Colorado
    • +5 more
    Oct 18, 2022

    Heart Failure Trial (Finerenone, Placebo)

    Not yet recruiting
    • Heart Failure
    • (no location specified)
    Sep 11, 2023

    Alcohol Use Disorder Trial in Columbus (Suvorexant, Placebo)

    Recruiting
    • Alcohol Use Disorder
    • Columbus, Ohio
      The Ohio State University
    Dec 11, 2022

    IL-6 and Its Receptor Antagonists in Children's Severe Sepsis.

    Withdrawn
    • Critical Illness Sepsis, Severe
      • (no location specified)
      Jun 13, 2022

      IL-1ß and Its Receptor Antagonists in Treatment of Severe

      Withdrawn
      • Critical Illness
      • Sepsis, Severe
        • (no location specified)
        Jun 13, 2022

        Cardiac Allograft Vasculopathy Trial in Los Angeles (Macitentan)

        Recruiting
        • Cardiac Allograft Vasculopathy
        • Los Angeles, California
          Ronald Regan UCLA Medical Center
        May 9, 2022

        Primary Hyperaldosteronism Due to Adrenal Adenoma Trial in Gothenburg, Stockholm, Umeå (Unilateral adrenalectomy, Medical

        Not yet recruiting
        • Primary Hyperaldosteronism Due to Adrenal Adenoma
        • Unilateral adrenalectomy
        • Medical treatment (eplerenone)
        • Gothenburg, Sweden
        • +2 more
        Mar 30, 2023

        s to Learn More About Treatment With Steroidal Mineralocorticoid

        Active, not recruiting
        • Chronic Kidney Disease
        • +2 more
        • sMRA therapies
        • Whippany, New Jersey
          Many Locations
        Jan 30, 2023

        Interleukin 6 Receptor Antagonists in Corona Virus Disease 19

        Recruiting
        • Corona Virus Infection
        • ELISA
        • Assiut, Egypt
          AssiutU
        Feb 2, 2023

        Type 1 Diabetes With Diabetic Nephropathy Trial in Worldwide (Sotagliflozin, Ambrisentan, Ambrisentan and Sotagliflozin)

        Not yet recruiting
        • Type 1 Diabetes Mellitus With Diabetic Nephropathy
        • Aurora, Colorado
        • +6 more
        Oct 2, 2023

        Pharmacologic Interaction Between ERAs and PDE-5 Inhibitors on

        Completed
        Has Results
        • Pulmonary Arterial Hypertension
        • no intervention, only observation of different groups
        • Heidelberg, Germany
          Centre for pulmonary hypertension, Thoraxclinic at the Universit
        Jan 24, 2020

        Heart Failure With Reduced Ejection Fraction Trial in New Haven (Best Practice Alert)

        Recruiting
        • Heart Failure With Reduced Ejection Fraction
        • Best Practice Alert
        • New Haven, Connecticut
          Cardiology/Internal Medicine Outpatient Clinics of Yale New Heal
        Jan 17, 2022

        Aortic Valve Stenosis, Valsartan, Angiotensin Receptor Antagonists Trial in Limoges (Valsartan, Placebo Oral Tablet)

        Not yet recruiting
        • Aortic Valve Stenosis
        • +5 more
        • Limoges, France
          Limoges university hospital
        Dec 23, 2022

        Anti-Angiotensin-Receptor 1-, Anti-Endothelin-Receptor

        Completed
        • Cardiac Failure
          • Wetzikon, Switzerland
            GZO Regional Health Center
          Jul 13, 2021

          Acute Pancreatitis Trial in Denmark (Placebo treatment, Methylnaltrexone treatment)

          Recruiting
          • Acute Pancreatitis
          • Placebo treatment
          • Methylnaltrexone treatment
          • Aalborg, Jutland, Denmark
          • +3 more
          Nov 23, 2021

          Exercise, Histamine Trial in Ghent (Placebo: Placebo + exercise training., H1 blockade: H1 receptor antagonist + exercise

          Active, not recruiting
          • Exercise
          • Histamine
          • Placebo: Placebo + exercise training.
          • +2 more
          • Ghent, Oost-Vlaanderen, Belgium
            Department of movement and sports sciences, Ghent University, Be
          Nov 8, 2022

          Vasculitis Trial in Edinburgh (BQ123, BQ123/788, Placebo)

          Completed
          • Vasculitis
          • Edinburgh, Midlothian, United Kingdom
          • +1 more
          Nov 30, 2020